Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Micrographs are representative images
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Common menstrual changes reported with Zepbound use People on Zepbound, Wegovy, or other GLP-1/GIP medications report several notable side effects specifically related to menstruation
This offer is only good for two years, and eligibility requirements apply
US$ 24.81
US$ 20.02
US$ 23.60
US$ 24.63
US$ 23.42
